Global Peptide Therapeutics Market Growth (Status and Outlook) 2022-2028
As the global economy mends, the 2021 growth of Peptide Therapeutics will have significant change from previous year. According to our latest study, the global Peptide Therapeutics market size is USD million in 2022 from USD 33800 million in 2021, with a change of % between 2021 and 2022. The global Peptide Therapeutics market size will reach USD 63130 million in 2028, growing at a CAGR of 9.3% over the analysis period.
The United States Peptide Therapeutics market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Peptide Therapeutics market, reaching US$ million by the year 2028. As for the Europe Peptide Therapeutics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Peptide Therapeutics players cover Sanofi, Teva, Novo Nordisk, and Takeda, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Peptide Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Injection
Oral
Other
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Cancer
Metabolic Disorders
Central Nervous System
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Sanofi
Teva
Novo Nordisk
Takeda
Eli Lilly
AstraZeneca
Novartis
AbbVie
Ipsen
Ferring
Merck
The Medicines
J & J
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Peptide Therapeutics Market Size 2017-2028
2.1.2 Peptide Therapeutics Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Peptide Therapeutics Segment by Type
2.2.1 Injection
2.2.2 Oral
2.2.3 Other
2.3 Peptide Therapeutics Market Size by Type
2.3.1 Peptide Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Peptide Therapeutics Market Size Market Share by Type (2017-2022)
2.4 Peptide Therapeutics Segment by Application
2.4.1 Cancer
2.4.2 Metabolic Disorders
2.4.3 Central Nervous System
2.4.4 Other
2.5 Peptide Therapeutics Market Size by Application
2.5.1 Peptide Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Peptide Therapeutics Market Size Market Share by Application (2017-2022)
3 Peptide Therapeutics Market Size by Player
3.1 Peptide Therapeutics Market Size Market Share by Players
3.1.1 Global Peptide Therapeutics Revenue by Players (2020-2022)
3.1.2 Global Peptide Therapeutics Revenue Market Share by Players (2020-2022)
3.2 Global Peptide Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Peptide Therapeutics by Regions
4.1 Peptide Therapeutics Market Size by Regions (2017-2022)
4.2 Americas Peptide Therapeutics Market Size Growth (2017-2022)
4.3 APAC Peptide Therapeutics Market Size Growth (2017-2022)
4.4 Europe Peptide Therapeutics Market Size Growth (2017-2022)
4.5 Middle East & Africa Peptide Therapeutics Market Size Growth (2017-2022)
5 Americas
5.1 Americas Peptide Therapeutics Market Size by Country (2017-2022)
5.2 Americas Peptide Therapeutics Market Size by Type (2017-2022)
5.3 Americas Peptide Therapeutics Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Peptide Therapeutics Market Size by Region (2017-2022)
6.2 APAC Peptide Therapeutics Market Size by Type (2017-2022)
6.3 APAC Peptide Therapeutics Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Peptide Therapeutics by Country (2017-2022)
7.2 Europe Peptide Therapeutics Market Size by Type (2017-2022)
7.3 Europe Peptide Therapeutics Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Peptide Therapeutics by Region (2017-2022)
8.2 Middle East & Africa Peptide Therapeutics Market Size by Type (2017-2022)
8.3 Middle East & Africa Peptide Therapeutics Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Peptide Therapeutics Market Forecast
10.1 Global Peptide Therapeutics Forecast by Regions (2023-2028)
10.1.1 Global Peptide Therapeutics Forecast by Regions (2023-2028)
10.1.2 Americas Peptide Therapeutics Forecast
10.1.3 APAC Peptide Therapeutics Forecast
10.1.4 Europe Peptide Therapeutics Forecast
10.1.5 Middle East & Africa Peptide Therapeutics Forecast
10.2 Americas Peptide Therapeutics Forecast by Country (2023-2028)
10.2.1 United States Peptide Therapeutics Market Forecast
10.2.2 Canada Peptide Therapeutics Market Forecast
10.2.3 Mexico Peptide Therapeutics Market Forecast
10.2.4 Brazil Peptide Therapeutics Market Forecast
10.3 APAC Peptide Therapeutics Forecast by Region (2023-2028)
10.3.1 China Peptide Therapeutics Market Forecast
10.3.2 Japan Peptide Therapeutics Market Forecast
10.3.3 Korea Peptide Therapeutics Market Forecast
10.3.4 Southeast Asia Peptide Therapeutics Market Forecast
10.3.5 India Peptide Therapeutics Market Forecast
10.3.6 Australia Peptide Therapeutics Market Forecast
10.4 Europe Peptide Therapeutics Forecast by Country (2023-2028)
10.4.1 Germany Peptide Therapeutics Market Forecast
10.4.2 France Peptide Therapeutics Market Forecast
10.4.3 UK Peptide Therapeutics Market Forecast
10.4.4 Italy Peptide Therapeutics Market Forecast
10.4.5 Russia Peptide Therapeutics Market Forecast
10.5 Middle East & Africa Peptide Therapeutics Forecast by Region (2023-2028)
10.5.1 Egypt Peptide Therapeutics Market Forecast
10.5.2 South Africa Peptide Therapeutics Market Forecast
10.5.3 Israel Peptide Therapeutics Market Forecast
10.5.4 Turkey Peptide Therapeutics Market Forecast
10.5.5 GCC Countries Peptide Therapeutics Market Forecast
10.6 Global Peptide Therapeutics Forecast by Type (2023-2028)
10.7 Global Peptide Therapeutics Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Peptide Therapeutics Product Offered
11.1.3 Sanofi Peptide Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Sanofi Main Business Overview
11.1.5 Sanofi Latest Developments
11.2 Teva
11.2.1 Teva Company Information
11.2.2 Teva Peptide Therapeutics Product Offered
11.2.3 Teva Peptide Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Teva Main Business Overview
11.2.5 Teva Latest Developments
11.3 Novo Nordisk
11.3.1 Novo Nordisk Company Information
11.3.2 Novo Nordisk Peptide Therapeutics Product Offered
11.3.3 Novo Nordisk Peptide Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Novo Nordisk Main Business Overview
11.3.5 Novo Nordisk Latest Developments
11.4 Takeda
11.4.1 Takeda Company Information
11.4.2 Takeda Peptide Therapeutics Product Offered
11.4.3 Takeda Peptide Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Takeda Main Business Overview
11.4.5 Takeda Latest Developments
11.5 Eli Lilly
11.5.1 Eli Lilly Company Information
11.5.2 Eli Lilly Peptide Therapeutics Product Offered
11.5.3 Eli Lilly Peptide Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Eli Lilly Main Business Overview
11.5.5 Eli Lilly Latest Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Company Information
11.6.2 AstraZeneca Peptide Therapeutics Product Offered
11.6.3 AstraZeneca Peptide Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 AstraZeneca Main Business Overview
11.6.5 AstraZeneca Latest Developments
11.7 Novartis
11.7.1 Novartis Company Information
11.7.2 Novartis Peptide Therapeutics Product Offered
11.7.3 Novartis Peptide Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Novartis Main Business Overview
11.7.5 Novartis Latest Developments
11.8 AbbVie
11.8.1 AbbVie Company Information
11.8.2 AbbVie Peptide Therapeutics Product Offered
11.8.3 AbbVie Peptide Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 AbbVie Main Business Overview
11.8.5 AbbVie Latest Developments
11.9 Ipsen
11.9.1 Ipsen Company Information
11.9.2 Ipsen Peptide Therapeutics Product Offered
11.9.3 Ipsen Peptide Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Ipsen Main Business Overview
11.9.5 Ipsen Latest Developments
11.10 Ferring
11.10.1 Ferring Company Information
11.10.2 Ferring Peptide Therapeutics Product Offered
11.10.3 Ferring Peptide Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Ferring Main Business Overview
11.10.5 Ferring Latest Developments
11. Merck
11.11.1 Merck Company Information
11.11.2 Merck Peptide Therapeutics Product Offered
11.11.3 Merck Peptide Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Merck Main Business Overview
11.11.5 Merck Latest Developments
11.12 The Medicines
11.12.1 The Medicines Company Information
11.12.2 The Medicines Peptide Therapeutics Product Offered
11.12.3 The Medicines Peptide Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 The Medicines Main Business Overview
11.12.5 The Medicines Latest Developments
11.13 J & J
11.13.1 J & J Company Information
11.13.2 J & J Peptide Therapeutics Product Offered
11.13.3 J & J Peptide Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 J & J Main Business Overview
11.13.5 J & J Latest Developments
12 Research Findings and Conclusion
List of Tables
Table 1. Peptide Therapeutics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Injection
Table 3. Major Players of Oral
Table 4. Major Players of Other
Table 5. Peptide Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Peptide Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Peptide Therapeutics Market Size Market Share by Type (2017-2022)
Table 8. Peptide Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Peptide Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Peptide Therapeutics Market Size Market Share by Application (2017-2022)
Table 11. Global Peptide Therapeutics Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Peptide Therapeutics Revenue Market Share by Player (2020-2022)
Table 13. Peptide Therapeutics Key Players Head office and Products Offered
Table 14. Peptide Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Peptide Therapeutics Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Peptide Therapeutics Market Size Market Share by Regions (2017-2022)
Table 19. Americas Peptide Therapeutics Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Peptide Therapeutics Market Size Market Share by Country (2017-2022)
Table 21. Americas Peptide Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Peptide Therapeutics Market Size Market Share by Type (2017-2022)
Table 23. Americas Peptide Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Peptide Therapeutics Market Size Market Share by Application (2017-2022)
Table 25. APAC Peptide Therapeutics Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Peptide Therapeutics Market Size Market Share by Region (2017-2022)
Table 27. APAC Peptide Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Peptide Therapeutics Market Size Market Share by Type (2017-2022)
Table 29. APAC Peptide Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Peptide Therapeutics Market Size Market Share by Application (2017-2022)
Table 31. Europe Peptide Therapeutics Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Peptide Therapeutics Market Size Market Share by Country (2017-2022)
Table 33. Europe Peptide Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Peptide Therapeutics Market Size Market Share by Type (2017-2022)
Table 35. Europe Peptide Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Peptide Therapeutics Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Peptide Therapeutics Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Peptide Therapeutics Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Peptide Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Peptide Therapeutics Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Peptide Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Peptide Therapeutics Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Peptide Therapeutics
Table 44. Key Market Challenges & Risks of Peptide Therapeutics
Table 45. Key Industry Trends of Peptide Therapeutics
Table 46. Global Peptide Therapeutics Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Peptide Therapeutics Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Peptide Therapeutics Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Peptide Therapeutics Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Peptide Therapeutics Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Peptide Therapeutics Market Size Market Share Forecast by Application (2023-2028)
Table 52. Sanofi Details, Company Type, Peptide Therapeutics Area Served and Its Competitors
Table 53. Sanofi Peptide Therapeutics Product Offered
Table 54. Sanofi Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. Sanofi Main Business
Table 56. Sanofi Latest Developments
Table 57. Teva Details, Company Type, Peptide Therapeutics Area Served and Its Competitors
Table 58. Teva Peptide Therapeutics Product Offered
Table 59. Teva Main Business
Table 60. Teva Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. Teva Latest Developments
Table 62. Novo Nordisk Details, Company Type, Peptide Therapeutics Area Served and Its Competitors
Table 63. Novo Nordisk Peptide Therapeutics Product Offered
Table 64. Novo Nordisk Main Business
Table 65. Novo Nordisk Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. Novo Nordisk Latest Developments
Table 67. Takeda Details, Company Type, Peptide Therapeutics Area Served and Its Competitors
Table 68. Takeda Peptide Therapeutics Product Offered
Table 69. Takeda Main Business
Table 70. Takeda Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. Takeda Latest Developments
Table 72. Eli Lilly Details, Company Type, Peptide Therapeutics Area Served and Its Competitors
Table 73. Eli Lilly Peptide Therapeutics Product Offered
Table 74. Eli Lilly Main Business
Table 75. Eli Lilly Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. Eli Lilly Latest Developments
Table 77. AstraZeneca Details, Company Type, Peptide Therapeutics Area Served and Its Competitors
Table 78. AstraZeneca Peptide Therapeutics Product Offered
Table 79. AstraZeneca Main Business
Table 80. AstraZeneca Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. AstraZeneca Latest Developments
Table 82. Novartis Details, Company Type, Peptide Therapeutics Area Served and Its Competitors
Table 83. Novartis Peptide Therapeutics Product Offered
Table 84. Novartis Main Business
Table 85. Novartis Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 86. Novartis Latest Developments
Table 87. AbbVie Details, Company Type, Peptide Therapeutics Area Served and Its Competitors
Table 88. AbbVie Peptide Therapeutics Product Offered
Table 89. AbbVie Main Business
Table 90. AbbVie Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 91. AbbVie Latest Developments
Table 92. Ipsen Details, Company Type, Peptide Therapeutics Area Served and Its Competitors
Table 93. Ipsen Peptide Therapeutics Product Offered
Table 94. Ipsen Main Business
Table 95. Ipsen Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 96. Ipsen Latest Developments
Table 97. Ferring Details, Company Type, Peptide Therapeutics Area Served and Its Competitors
Table 98. Ferring Peptide Therapeutics Product Offered
Table 99. Ferring Main Business
Table 100. Ferring Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 101. Ferring Latest Developments
Table 102. Merck Details, Company Type, Peptide Therapeutics Area Served and Its Competitors
Table 103. Merck Peptide Therapeutics Product Offered
Table 104. Merck Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 105. Merck Main Business
Table 106. Merck Latest Developments
Table 107. The Medicines Details, Company Type, Peptide Therapeutics Area Served and Its Competitors
Table 108. The Medicines Peptide Therapeutics Product Offered
Table 109. The Medicines Main Business
Table 110. The Medicines Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 111. The Medicines Latest Developments
Table 112. J & J Details, Company Type, Peptide Therapeutics Area Served and Its Competitors
Table 113. J & J Peptide Therapeutics Product Offered
Table 114. J & J Main Business
Table 115. J & J Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 116. J & J Latest Developments
List of Figures
Figure 1. Peptide Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Peptide Therapeutics Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Peptide Therapeutics Market Size Market Share by Type in 2021
Figure 7. Peptide Therapeutics in Cancer
Figure 8. Global Peptide Therapeutics Market: Cancer (2017-2022) & ($ Millions)
Figure 9. Peptide Therapeutics in Metabolic Disorders
Figure 10. Global Peptide Therapeutics Market: Metabolic Disorders (2017-2022) & ($ Millions)
Figure 11. Peptide Therapeutics in Central Nervous System
Figure 12. Global Peptide Therapeutics Market: Central Nervous System (2017-2022) & ($ Millions)
Figure 13. Peptide Therapeutics in Other
Figure 14. Global Peptide Therapeutics Market: Other (2017-2022) & ($ Millions)
Figure 15. Global Peptide Therapeutics Market Size Market Share by Application in 2021
Figure 16. Global Peptide Therapeutics Revenue Market Share by Player in 2021
Figure 17. Global Peptide Therapeutics Market Size Market Share by Regions (2017-2022)
Figure 18. Americas Peptide Therapeutics Market Size 2017-2022 ($ Millions)
Figure 19. APAC Peptide Therapeutics Market Size 2017-2022 ($ Millions)
Figure 20. Europe Peptide Therapeutics Market Size 2017-2022 ($ Millions)
Figure 21. Middle East & Africa Peptide Therapeutics Market Size 2017-2022 ($ Millions)
Figure 22. Americas Peptide Therapeutics Value Market Share by Country in 2021
Figure 23. Americas Peptide Therapeutics Consumption Market Share by Type in 2021
Figure 24. Americas Peptide Therapeutics Market Size Market Share by Application in 2021
Figure 25. United States Peptide Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 26. Canada Peptide Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 27. Mexico Peptide Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 28. Brazil Peptide Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 29. APAC Peptide Therapeutics Market Size Market Share by Region in 2021
Figure 30. APAC Peptide Therapeutics Market Size Market Share by Application in 2021
Figure 31. China Peptide Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 32. Japan Peptide Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 33. Korea Peptide Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 34. Southeast Asia Peptide Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 35. India Peptide Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 36. Australia Peptide Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 37. Europe Peptide Therapeutics Market Size Market Share by Country in 2021
Figure 38. Europe Peptide Therapeutics Market Size Market Share by Type in 2021
Figure 39. Europe Peptide Therapeutics Market Size Market Share by Application in 2021
Figure 40. Germany Peptide Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 41. France Peptide Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 42. UK Peptide Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 43. Italy Peptide Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 44. Russia Peptide Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 45. Middle East & Africa Peptide Therapeutics Market Size Market Share by Region in 2021
Figure 46. Middle East & Africa Peptide Therapeutics Market Size Market Share by Type in 2021
Figure 47. Middle East & Africa Peptide Therapeutics Market Size Market Share by Application in 2021
Figure 48. Egypt Peptide Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 49. South Africa Peptide Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 50. Israel Peptide Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 51. Turkey Peptide Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 52. GCC Country Peptide Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 53. Americas Peptide Therapeutics Market Size 2023-2028 ($ Millions)
Figure 54. APAC Peptide Therapeutics Market Size 2023-2028 ($ Millions)
Figure 55. Europe Peptide Therapeutics Market Size 2023-2028 ($ Millions)
Figure 56. Middle East & Africa Peptide Therapeutics Market Size 2023-2028 ($ Millions)
Figure 57. United States Peptide Therapeutics Market Size 2023-2028 ($ Millions)
Figure 58. Canada Peptide Therapeutics Market Size 2023-2028 ($ Millions)
Figure 59. Mexico Peptide Therapeutics Market Size 2023-2028 ($ Millions)
Figure 60. Brazil Peptide Therapeutics Market Size 2023-2028 ($ Millions)
Figure 61. China Peptide Therapeutics Market Size 2023-2028 ($ Millions)
Figure 62. Japan Peptide Therapeutics Market Size 2023-2028 ($ Millions)
Figure 63. Korea Peptide Therapeutics Market Size 2023-2028 ($ Millions)
Figure 64. Southeast Asia Peptide Therapeutics Market Size 2023-2028 ($ Millions)
Figure 65. India Peptide Therapeutics Market Size 2023-2028 ($ Millions)
Figure 66. Australia Peptide Therapeutics Market Size 2023-2028 ($ Millions)
Figure 67. Germany Peptide Therapeutics Market Size 2023-2028 ($ Millions)
Figure 68. France Peptide Therapeutics Market Size 2023-2028 ($ Millions)
Figure 69. UK Peptide Therapeutics Market Size 2023-2028 ($ Millions)
Figure 70. Italy Peptide Therapeutics Market Size 2023-2028 ($ Millions)
Figure 71. Russia Peptide Therapeutics Market Size 2023-2028 ($ Millions)
Figure 72. Spain Peptide Therapeutics Market Size 2023-2028 ($ Millions)
Figure 73. Egypt Peptide Therapeutics Market Size 2023-2028 ($ Millions)
Figure 74. South Africa Peptide Therapeutics Market Size 2023-2028 ($ Millions)
Figure 75. Israel Peptide Therapeutics Market Size 2023-2028 ($ Millions)
Figure 76. Turkey Peptide Therapeutics Market Size 2023-2028 ($ Millions)
Figure 77. GCC Countries Peptide Therapeutics Market Size 2023-2028 ($ Millions)
